Cutler Group LP Aravive, Inc. Call Options Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Jan 18, 2022	SELL	$2.19 - $4.07 $2,409 - $4,477	-1,100 Closed	0 $0
Q3 2021 Oct 26, 2021	BUY	$3.67 - $5.8 $4,037 - $6,380	1,100 New	1,100 $0
Q1 2020 May 07, 2020	SELL	$3.5 - $13.77 $3,850 - $15,147	-1,100 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$6.21 - $14.02 $6,831 - $15,422	1,100 New	1,100 $3,000

28.1K

Ticker ARAV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,518,300
Description
Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.